Skip to content
Screener

Glaukos GKOS G&A

G&A at other companies

Schering-Plough logo
Schering-PloughSGP
$6.87M+401%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$20.01M+22.4%
Staar Surgical logo
Staar SurgicalSTAA
$17.02M-30.4%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$11.23M-27.2%

Segments

By segment

See full
Development And Commercialization Of Ophthalmic Therapies$59.45M+37.1%

Other financials

Income statement

See full
Revenue$185.6M+49.5%
Gross profit$151.6M+55.9%
Operating income-$17.3M+23.9%
Net income-$18.4M+6.5%
EPS (diluted)-$0.31+8.8%

Balance sheet

See full
Cash & equivalents$114.5M+13.6%
Total debt$105.9M-1.4%
Total equity$682.5M-10.8%
Total assets$920.5M-6.7%

Cash flow

See full
Operating cash flow$14.8M—
CapEx$2.7M+132%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$10.08B+98.7%
Enterprise value$10.07B+98.2%
P/S16.5×+4.7×

Profitability

See full
Gross margin61%-15.4pp
Operating margin-31.6%+22.2pp
Net margin-30.7%+23.3pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26%-11,301pp
Debt / equity0.2×0.0×
Current ratio5×-0.5×

FAQ

What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.